Brevilin A

Products

Inquiry

Cat. No.: IBDI-431153

Brevilin A is an orally active STAT3/JAK inhibitor (STAT3 IC50= 10.6 µM). Brevilin A shows anti-tumor activity, anti-proliferative activity to cancer cells, and can induce apoptosis and autophagy.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target	JAK \| STAT \| Apoptosis \| Autophagy
Molecular Weight	346.42
Appearance	Solid
SMILES	C/C=C(C)\C(O[[email protected]]1[[email protected]@]([[email protected]@H]2C)([H])[[email protected]@](OC2=O)([H])C[[email protected]@H](C)[[email protected]@]3([H])[[email protected]]1(C(C=C3)=O)C)=O
Structure Classification	Terpenoids>Sesquiterpenes
Purity	99.71%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Powder: -20°C/3 years; 4°C/2 years In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.